This biotech CEO secured two billion-dollar Big Pharma deals during the pandemic
PharmaVoice
JANUARY 31, 2023
With the industry focused on cancer and COVID-19, Marc de Garidel made deals centered on cardio.
PharmaVoice
JANUARY 31, 2023
With the industry focused on cancer and COVID-19, Marc de Garidel made deals centered on cardio.
PhRMA
JANUARY 31, 2023
Middlemen don’t want patients to know how they are stacking the deck against them.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
JANUARY 31, 2023
Adalimumab-atto was first approved by the FDA in 2016.
PhRMA
JANUARY 31, 2023
PhRMA recently submitted comments to the Office of the U.S. Trade Representative (USTR)’s 2023 Special 301 Report. The comments highlight foreign government actions and policies that undermine American innovation, biopharmaceutical leadership and more than 4.4 million American jobs.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Fierce Pharma
JANUARY 31, 2023
Pfizer warns Comirnaty sales will plummet by nearly two-thirds in 2023.
Fierce Healthcare
JANUARY 31, 2023
COVID-19 vaccines, boosters keep kids out of the ER: study fdiamond Tue, 01/31/2023 - 15:33
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Drug Store News
JANUARY 31, 2023
MedAvail has agreed to sell to CVS certain assets related to its SpotRx pharmacies located in Arizona, California, Michigan and Florida.
Fierce Healthcare
JANUARY 31, 2023
GOP lawmakers ready to scrap Oracle Cerner's $16B VA contract unless 'deeply flawed' EHR fixed hlandi Tue, 01/31/2023 - 20:39
Pharmaceutical Technology
JANUARY 31, 2023
Gene therapy company uniQure has entered into a global licensing agreement with Apic Bio for APB-102 to treat patients with amyotrophic lateral sclerosis (ALS) caused by mutations in superoxide dismutase 1 (SOD1). Under the terms of the deal, uniQure will obtain the worldwide rights to develop and market the clinical stage gene therapy, APB-102. uniQure stated that the license of APB-102 further strengthens its gene therapies pipeline developed for the treatment of neurological disorders as well
Fierce Healthcare
JANUARY 31, 2023
Employers hope to address parents' concerns about their kids' mental health fdiamond Tue, 01/31/2023 - 07:39
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Drug Store News
JANUARY 31, 2023
Designed to provide consumers with a cleaner formula solution that works to eliminate dandruff, the line is pH-optimized and dermatologist tested.
Fierce Healthcare
JANUARY 31, 2023
Former Oracle exec Troy Tazbaz tapped as FDA director of digital health aburky Tue, 01/31/2023 - 15:29
Drug Store News
JANUARY 31, 2023
The brand’s new Vibrant collection is infused with natural essential oils that look to help consumers set the mood of their home.
Fierce Pharma
JANUARY 31, 2023
In mysterious FDA approval, Pfizer quietly wins Ibrance breast cancer expansion aliu Tue, 01/31/2023 - 10:37
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Drug Store News
JANUARY 31, 2023
John Garratt, president and CFO at Dollar General, has announced his intent to retire, effective June 2.
STAT
JANUARY 31, 2023
The White House’s Covid Winter Preparedness Plan is a missed opportunity to narrow the divide between Americans. The plan contains important elements to mitigate the anticipated seasonal surge of Covid-19. But it sidesteps the emerging evidence base and President Biden’s pledge to “follow the science.” The current “later Omicron” endemic phase, which began with the rise of the more communicable and less virulent BA.4 and BA.5 subvariants in May 2022, str
Fierce Pharma
JANUARY 31, 2023
Amgen's Humira biosimilar Amjevita hits the market with two different list prices zbecker Tue, 01/31/2023 - 10:58
Fierce Healthcare
JANUARY 31, 2023
CVS Health goes live with virtual care service with a focus on primary care, mental health hlandi Tue, 01/31/2023 - 13:54
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
STAT
JANUARY 31, 2023
Big Tech has gone through a rough stretch of layoffs — between Meta, Amazon, Alphabet, and Microsoft, 51,000 people have lost their jobs since November 2022, including 12,000 cuts this month at Alphabet alone. Alphabet’s layoffs didn’t hit its health care teams head on: Rather, laid-off employees told STAT, the cuts were scattered across the company.
Fierce Healthcare
JANUARY 31, 2023
Blue Shield of California teams with Accolade on new virtual-first plan pminemyer Tue, 01/31/2023 - 15:58
STAT
JANUARY 31, 2023
Underscoring the opaque and confusing nature of pharmaceutical pricing, Amgen announced long-awaited pricing for its biosimilar version of Humira – the world’s best-selling medicine – and the numbers suggest the biggest winners may be health insurers and others in the supply chain, but not patients. Here’s why: The drug company will offer its medication, called Amjevita, at two different discounts – 5% and 55% – off the roughly $80,000 wholesale, or list
The Checkup by Singlecare
JANUARY 31, 2023
This January, one-third of Americans made New Year’s resolutions, and The Checkup is full of ideas to help you reach your 2023 health goals. If you are trying to lose weight, and your provider prescribed a weight-loss medication, you’ll find ways to save. Or if you’ve made the decision to quit smoking, but you’ve been experiencing insomnia as a result, check out 11 tips to get a better night’s sleep.
STAT
JANUARY 31, 2023
SAN FRANCISCO — Part of Andy Slavitt’s core mission at Town Hall Ventures is proving that health tech companies can make a viable business out of reaching low-income people who also face social challenges, like a lack of housing or nutritious food options. It’s a bold assertion that hasn’t been proven out yet, though a handful of Town Hall Ventures’ portfolio companies — including Unite Us and Alphabet spinout Cityblock — have already achie
Fierce Healthcare
JANUARY 31, 2023
Federal appeals court sides with drugmakers on 340B contract pharmacy restrictions dmuoio Tue, 01/31/2023 - 12:50
STAT
JANUARY 31, 2023
A Medicare official hinted Tuesday that Medicare might test a policy of paying less for drugs that receive so-called accelerated approvals than for drugs that are granted traditional approvals. The Food and Drug Administration uses accelerated approvals to make promising drugs for serious conditions available to patients sooner. The program is widely considered a success and has worked well for many drugs, including the leukemia drug Gleevec , which the FDA approved in 2001 after a review period
Drug Store News
JANUARY 31, 2023
Among the 78% of Americans who are vitamin users, 34% have increased their usage since the start of the COVID-19 pandemic, including nearly half of millennials, according to Mintel research.
Board Vitals - Pharmacist
JANUARY 31, 2023
On February 12, the Philadelphia Eagles and Kansas City Chiefs will duke it out in Super Bowl LVII. In addition to the players on the field, there are teams of NFL team doctors and sports medicine specialists who keep the offenses, defenses, and special teams in top shape. According to the NFL Physicians Society (NFLPS), 192 team physicians (as of 2023) provide care to the 32 NFL teams and their players – on and off the field, and long before and after game time.
Drug Store News
JANUARY 31, 2023
Drug chains face unique challenges when it comes to reimagining a category: They often have smaller stores, cannot carry upscale brands and focus heavily on pharmacy.
European Pharmaceutical Review
JANUARY 31, 2023
The European Commission (EC) has expanded the marketing authorisation for Dupixent® (dupilumab) in the European Union (EU) to treat eosinophilic esophagitis (EoE). It is the “… first and only targeted treatment option clinically proven to reduce both oesophageal inflammation and damage,” explained Dr Naimish Patel, Head of Global Development, Immunology and Inflammation at Sanofi.
STAT
JANUARY 31, 2023
January 31 is set to mark the start of a watershed year for the biosimilars industry with the release of Amjevita, the first biosimilar for Humira, the world’s best-selling drug. Several more Humira biosimilars will also be released this year. But without support from regulators and policymakers to make all biosimilars available on formularies, the full promise of these price-cutting drugs could be lost, costing the U.S. health care system $133 billion in the next three years.
Drug Store News
JANUARY 31, 2023
In its 90th year, NACDS remains focused on the ever-evolving goal of leading the future of an industry dedicated to advancing health and wellness for all Americans.
The Checkup by Singlecare
JANUARY 31, 2023
Protonix ( pantoprazole ) is a medication prescribed to treat a variety of digestive issues, including heartburn , acid reflux, gastroesophageal reflux disease (GERD) , Zollinger-Ellison Syndrome, and duodenal ulcers. It works by decreasing the amount of acid your stomach creates. Since these are all gastrointestinal issues, it makes sense there would be some restrictions on what you can eat and drink.
Fierce Healthcare
JANUARY 31, 2023
Texas doctors file new surprise billing lawsuit challenging arbitration fees rking Tue, 01/31/2023 - 18:00
Let's personalize your content